Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis
John Forbes(University of Edinburgh), Andrew W. Bradbury(University of Birmingham), F. G. R. Fowkes(University of Edinburgh), Ian Gillespie(Edinburgh Royal Infirmary), C V Ruckley(University of Edinburgh), Jocelyn Bell(University of Birmingham), Donald J. Adam(University Hospitals Birmingham NHS Foundation Trust), Gillian Raab(Scotch Whisky Research Institute)
Cited by 130
Related Papers
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy
|Journal of Vascular Surgery|2010|581
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received
|Journal of Vascular Surgery|2010|358
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making
|Journal of Vascular Surgery|2010|246